Fortis Life Sciences offers reagents, tools, materials, and custom services for the biopharma industry, with the aim to offer a best-in-class customer experience. Through our nanoComposix brand, we provide precisely engineered and highly characterised nanomaterials to a global customer base.
nanoComposix is an ISO 13485 (2016) certified developer and contract manufacturer registered with the US Food and Drug Administration (FDA). We have a nanomaterial product portfolio containing various materials, which are developed in line with good manufacturing practice (GMP) standards and to meet customers’ needs.
Our products and contract development and manufacturing organisation (CDMO) services are supported by technical teams with extensive expertise in nanotechnology, biology, chemistry, and therapeutics.
Biopharma contract research and development services
nanoComposix has successfully completed hundreds of custom manufacturing and collaborative research and development (R&D) projects for governmental, academic, and industrial customers in a wide range of sectors. Within the pharmaceutical industry, these have included photothermal acne treatments, GMP topical therapeutics, prostate cancer drugs, and composite wound compression dressings.
We increasingly function as a ‘plug-in’ R&D and manufacturing component for companies that need to rapidly take a concept from feasibility through scale-up to commercial manufacturing. In these cases, we provide a confidential work environment in which technology and intellectual property are used to maximise future value for our customers.
Nanomaterial development for nanomedicine applications
nanoComposix provides solutions for the rapid development and commercialisation of medical devices and therapeutic products. There are many nanomaterial companies and GMP manufacturers, but few companies that specialise in both areas.
With our expertise in nanoparticle fabrication for targeted delivery, controlled-release photothermal therapy, and biofunctionalisation, we aim to help partners bring high-impact, nano-enabled products to market.
Our capabilities include customising the composition, size, surface chemistry, concentration, optical properties, and soft material chemistry of nanomaterials in line with project needs.
GMP nanomaterial synthesis and manufacturing
nanoComposix specialises in the development and manufacturing of devices and drugs with nanomaterial components. Our team offers support throughout the nanoparticle manufacturing process, including proof of concept clinical trials, scaled production, and current GMP (cGMP) manufacturing.
Our wide range of capabilities allows us to provide expert advice throughout the manufacturing process. We can also provide support with the fabrication and scale-up of nanomaterials for products that must be developed and produced in cGMP-compliant quality systems.
Tailored GMP nanoparticle manufacturing services
nanoComposix works through a multi-stage process with each of our clients to collaboratively develop a GMP Project Plan, which can then be customised for the target application while maintaining cost efficiency and compliance.
Our lead scientists have more than 80 years of collective experience in nanomaterial fabrication, with an emphasis on metals and metal oxides such as gold, silver, silica, and polymers.
Our facility offers production under the controls of our cGMP compliant / ISO 13485-certified quality management system. It enables scaled nanoparticle manufacturing for medical devices, topical therapeutics, and drug-device combination products for preclinical and Phase I and II clinical trials, as well as certain commercial applications.
Based in San Diego, California, nanoComposix was founded in 2004 with the aim to provide accurate custom nanomaterials for clients worldwide.
Our status as an ISO 13485 (2016) certified, FDA-registered developer and contract manufacturer helps us ensure all our products and services are of the highest quality and can continue to meet customer expectations.